Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Anliker

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Zeitschrift Fur Gerontologie Und Geriatrie|February 14, 2015
[Resident assessment instrument in Switzerland. History, results and experiences from the application]Markus Anliker, Guido Bartelt
Praxis|August 17, 2022
[Polypharmacy and Neuroleptics in Swiss Nursing Homes in the Years 2019 and 2020]Max Giger, Markus Anliker, Guido Bartelt
Immunohematology|May 18, 2016
CD59: A long-known complement inhibitor has advanced to a blood group systemChristof Weinstock, Markus Anliker, Inge von Zabern
Therapeutische Umschau. Revue Therapeutique|September 16, 2008
[Laboratory assessment of osteoporosis]Marius E Kraenzlin, Markus Anliker, Andrea Griesmacher
Immunohematology|March 26, 2019
An update on the CD59 blood group systemChristof Weinstock, Markus Anliker, Inge von Zabern
Cytometry. Part B, Clinical Cytometry|January 24, 2018
The Monoclonal Anti-CD157 Antibody Clone SY11B5, Used for High Sensitivity Detection of PNH Clones on WBCs, Fails to Detect a Common Polymorphic Variant Encoded by BST-1Johanna Blaha, Klaus Schwarz, Claudia Fischer, et al.
Scientific Reports|February 28, 2023
Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropeniaChristina Salvador, Andreas Meryk, Benjamin Hetzer, et al.
International Journal of Laboratory Hematology|May 17, 2023
Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assayChristian Irsara, Markus Anliker, Alexander E Egger, et al.
Clinical Chemistry and Laboratory Medicine|July 2, 2025
Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2<sup>V617F</sup> mutated myeloproliferative disordersChristoph Winkler, Markus Anliker, Stefan Schmidt, et al.
Clinical and Experimental Immunology|October 22, 2024
Expression of sPD-L1 levels in an ex vivo liver perfusion modelChristian Irsara, Annemarie Weissenbacher, Felix Julius Krendl, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Zeitschrift Fur Gerontologie Und Geriatrie|February 14, 2015
[Resident assessment instrument in Switzerland. History, results and experiences from the application]Markus Anliker, Guido Bartelt
Praxis|August 17, 2022
[Polypharmacy and Neuroleptics in Swiss Nursing Homes in the Years 2019 and 2020]Max Giger, Markus Anliker, Guido Bartelt
Immunohematology|May 18, 2016
CD59: A long-known complement inhibitor has advanced to a blood group systemChristof Weinstock, Markus Anliker, Inge von Zabern
Therapeutische Umschau. Revue Therapeutique|September 16, 2008
[Laboratory assessment of osteoporosis]Marius E Kraenzlin, Markus Anliker, Andrea Griesmacher
Immunohematology|March 26, 2019
An update on the CD59 blood group systemChristof Weinstock, Markus Anliker, Inge von Zabern
Cytometry. Part B, Clinical Cytometry|January 24, 2018
The Monoclonal Anti-CD157 Antibody Clone SY11B5, Used for High Sensitivity Detection of PNH Clones on WBCs, Fails to Detect a Common Polymorphic Variant Encoded by BST-1Johanna Blaha, Klaus Schwarz, Claudia Fischer, et al.
Scientific Reports|February 28, 2023
Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropeniaChristina Salvador, Andreas Meryk, Benjamin Hetzer, et al.
International Journal of Laboratory Hematology|May 17, 2023
Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assayChristian Irsara, Markus Anliker, Alexander E Egger, et al.
Clinical Chemistry and Laboratory Medicine|July 2, 2025
Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2<sup>V617F</sup> mutated myeloproliferative disordersChristoph Winkler, Markus Anliker, Stefan Schmidt, et al.
Clinical and Experimental Immunology|October 22, 2024
Expression of sPD-L1 levels in an ex vivo liver perfusion modelChristian Irsara, Annemarie Weissenbacher, Felix Julius Krendl, et al.
Pageof 4